多靶点脑深部电刺激治疗癫痫
单中心回顾性研究纳入8例药物难治性癫痫成人患者,接受2—3个不同丘脑/丘脑下核团的多靶点脑深部电刺激(DBS),每侧半球2根电极,无手术并发症;随访超过6个月的5例患者整体发作频率和/或惊厥发作频率均减少≥50%。作者认为多靶点DBS操作可行且安全,需足够把握度的未来研究评估其疗效。
要点
- 8例复杂癫痫患者接受2—3个丘脑/丘脑下核团多靶点DBS,每侧半球植入2根电极,无手术并发症。
- 随访超过6个月的5例患者中,整体发作频率和/或惊厥发作频率均减少≥50%。
- 2例出现刺激相关不良反应,经进一步程控后缓解。
核心结论
- 多靶点DBS是使复杂癫痫患者结局最大化的操作可行且安全的治疗策略;作者强调其方法可為未来足够把握度的疗效研究提供参考。
研究设计与样本
- 单中心回顾性研究,纳入接受多靶点DBS的成人药物难治性癫痫患者8例,DBS靶点包括前丘脑核(ANT)、中央中核(CM)及研究较少的丘脑内侧核、枕核和丘脑底核。
- 采用多靶点DBS以展示该方法的可行性与安全性并报告发作结局;患者癫痫特征包括多灶/多脑叶、弥漫性起病和/或后部起病,或全面性与局灶性发作并存。
主要发现
- 8例患者接受2—3个不同丘脑/丘脑下核团的DBS,每侧半球2根电极,所有电极经额部或顶部轨迹植入,无手术并发症。
- 随访超过6个月者5例(随访范围7—21个月),全部为应答者,即整体发作频率和/或惊厥发作频率减少≥50%。
- 2例出现刺激相关不良反应,经进一步程控后缓解。
临床怎么用
- 本研究中心的做法是:对不符合ANT或CM单靶点DBS试验所代表人群的DBS候选者,采用包括ANT、CM及研究较少的丘脑内侧核、枕核和丘脑底核在内的多靶点DBS。
局限性
- 单中心回顾性研究。
- 样本量为8例,随访超过6个月者仅5例。
- 作者指出需未来足够把握度的研究评估其疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Deep brain stimulation (DBS) is a rapidly growing surgical option for patients with drug-resistant epilepsy who are not candidates for resective/ablative surgery. Recent randomized controlled trials have demonstrated efficacy of DBS of the anterior nucleus of the thalamus (ANT), particularly in frontal or temporal epilepsy, whereas DBS of the centromedian (CM) nucleus appears to be most suitable in well-defined generalized epilepsy syndromes. At the authors' institution, DBS candidates who did not fit the populations represented in these trials were managed with DBS of multiple distinct targets, which included ANT, CM, and less-studied nuclei-i.e., mediodorsal nucleus, pulvinar, and subthalamic nucleus. The goal of this study was to present the authors' experience with these types of cases, and to motivate future investigations that can determine the long-term efficacy of multitarget DBS. METHODS: This single-center retrospective study of adult patients with drug-resistant epilepsy who underwent multitarget DBS was performed to demonstrate the feasibility and safety of this approach, and to present seizure outcomes. Patients in this cohort had epilepsy with features that were difficult to treat with DBS of the ANT or CM nucleus alone, including multifocal/multilobar, diffuse-onset, and/or posterior-onset seizures; or both generalized and focal seizures. RESULTS: Eight patients underwent DBS of 2-3 distinct thalamic/subthalamic nuclei. DBS was performed with 2 electrodes in each hemisphere. All leads in each patient were implanted with either frontal or parietal trajectories. There were no surgical complications. Among those with > 6 months of follow-up (n = 5; range 7-21 months), all patients were responders in terms of overall seizure frequency and/or convulsive seizure frequency (i.e., ≥ 50% reduction). Two patients had adverse stimulation effects, which resolved with further programming. CONCLUSIONS: Multitarget DBS is a procedurally feasible and safe treatment strategy to maximize outcomes in patients with complex epilepsy. The authors highlight their approach to inform future studies that are sufficiently powered to assess its efficacy.
引用
- Yang AI, Isbaine F, Alwaki A, et al. Multitarget deep brain stimulation for epilepsy. J Neurosurg. 2023. PMID: 37486888. doi:10.3171/2023.5.JNS23982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。